Citrini Research is backing life sciences stocks after using Claude to design proteins

What happened: Citrini Research used Claude to design proteins and is backing life sciences stocks after the work, with 211 proteins designed for lab testing. Key numbers: 211 proteins designed; 17 bound to scorpion toxins; blocking effects untested. Why it matters: The firm's move into life sciences stocks follows its AI-assisted protein design work, though the blocking effects of the 17 binding proteins remain untested.

Citrini Research used Claude to design proteins and is backing life sciences stocks after the work, with 211 proteins designed for lab testing.

The firm's move into life sciences stocks follows its AI-assisted protein design work, though the blocking effects of the 17 binding proteins remain untested.